Gold nanoparticles as an efficient drug delivery system for GLP - 1 peptides
Author
dc.contributor.author
Pérez Ortiz, Magdalena
Author
dc.contributor.author
Zapata Urzua, Claudio
Author
dc.contributor.author
Acosta, Gerardo A.
Author
dc.contributor.author
Álvarez Lueje, Alejandro
Author
dc.contributor.author
Albericio, Fernando
Author
dc.contributor.author
Kogan Bocian, Marcelo
Admission date
dc.date.accessioned
2018-06-13T20:02:20Z
Available date
dc.date.available
2018-06-13T20:02:20Z
Publication date
dc.date.issued
2017
Cita de ítem
dc.identifier.citation
Colloids and Surfaces B: Biointerfaces 158 (2017) 25–32
es_ES
Identifier
dc.identifier.other
10.1016/j.colsurfb.2017.06.015
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/148846
Abstract
dc.description.abstract
In this work, the potential application of gold nanoparticles for GLP-1 analogues delivery was studied. For this purpose, the original sequence of the incretin GLP-1 was slightly modified in the C-terminal region by adding a cysteine residue to facilitate conjugation to the gold surface. The interaction between peptides and gold nanoparticles and also the colloid stability of the conjugates were studied by UV-vis spectrophotometry, TEM, IR and XPS spectroscopy. Moreover, the permeability of these conjugates was assayed using a Caco-2/goblet monolayer model. On the basis of the stability and permeability results, one of the conjugates was chosen to be administered intraperitoneally to normoglycemic rats. The intraperitoneal delivery of the GLP-1 analogue using gold nanoparticles led to decrease levels of blood glucose in the same way as native GLP-1, thereby demonstrating that the formulation of the analogue is stable in physiological conditions and maintains the activity of this incretin. (C) 2017 Elsevier B.V. All rights reserved.
es_ES
Patrocinador
dc.description.sponsorship
CONICYT (Chile)
ATD-24110090
AECID (Spain)
A1/035396/11
CONICYT
Vicerectory of Academic Issues (University of Chile)
Fondap
15130011